Predicting HIV Disease Progression in Children Using Measures of Neuropsychological and Neurological Functioning by Pearson, Deborah A, McGrath, Nuala M, Nozyce, Molly, Nichols, Sharon L, Raskino, Claire, Brouwers, Pim, Lifschitz, Marta C, Baker, Carol J, Englund, Janet A, Pediatric AIDS Clinical Trials 152 Study Team

Get full text

Genetic Influence of CCR5, CCR2 and SDF1 Variants on Human Immunodeficiency Virus 1 (HIV-1)–Related Disease Progression and Neurological Impairment, in Children with Symptomatic HI... by Singh, Kumud K., Barroga, Charlene F., Hughes, Michael D., Chen, Jie, Raskino, Claire, McKinney, Ross E., Spector, Stephen A.

Get full text

Factors affecting the maintenance dose of warfarin by James, A H, Britt, R P, Raskino, C L, Thompson, S G

Get full text

Predictive Value of Quantitative Plasma HIV RNA and CD4+ Lymphocyte Count in HIV-Infected Infants and Children by Palumbo, Paul E, Raskino, Claire, Fiscus, Susan, Pahwa, Savita, Fowler, Mary G, Spector, Stephen A, Englund, Janet A, Baker, Carol J

Get full text

Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS clinical trials 152 study team by Pearson, D A, McGrath, N M, Nozyce, M, Nichols, S L, Raskino, C, Brouwers, P, Lifschitz, M C, Baker, C J, Englund, J A

Get full text

Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clini... by Raskino, C, Pearson, D A, Baker, C J, Lifschitz, M H, O'Donnell, K, Mintz, M, Nozyce, M, Brouwers, P, McKinney, R E, Jimenez, E, Englund, J A

Get full text

Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register by HENDERSON, R.A., RASKINO, C.L., HAMPTON, J.R.

Get full text

Short-Term Safety and Antiretroviral Activity of T-1249, a Second-Generation Fusion Inhibitor of HIV by Eron, Joseph J., Gulick, Roy M., Bartlett, John A., Merigan, Thomas, Arduino, Roberto, Kilby, J. Michael, Yangco, Bienvenido, Diers, Adriann, Drobnes, Claude, DeMasi, Ralph, Greenberg, Michael, Melby, Thomas, Raskino, Claire, Rusnak, Pam, Zhang, Ying, Spence, Rebecca, Miralles, G. Diego

Get full text

T-1249 Retains Potent Antiretroviral Activity in Patients Who Had Experienced Virological Failure while on an Enfuvirtide-Containing Treatment Regimen by Lalezari, Jacob P., Bellos, Nicholaos C., Sathasivam, Kunthavi, Richmond, Gary J., Cohen, Calvin J., Myers, Robert A., Henry, David H., Raskino, Claire, Melby, Tom, Murchison, Hugh, Zhang, Ying, Spence, Rebecca, Greenberg, Michael L., DeMasi, Ralph A., Miralles, G. Diego

Get full text

Neurologic, Neurocognitive, and Brain Growth Outcomes in Human Immunodeficiency Virus-Infected Children Receiving Different Nucleoside Antiretroviral Regimens by Raskino, Claire, Pearson, Deborah A, Baker, Carol J, Lifschitz, Marta H, O'Donnell, Karen, Mintz, Mark, Nozyce, Molly, Brouwers, Pim, McKinney, Ross E, Jimenez, Eleanor, Englund, Janet A, Pediatric AIDS Clinical Trials Group 152 Study Team

Get full text

Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children: Englund J.A.; Baker C.J.; Raskino C.; McKinney R.E.; Petrie B.; Fowler M.G.; Pearson D.; Gershon A.; McSherry G.D.; Abrams E.J.; Schliozberg J.; Sullivan J.L. USA New Engl J Med 1997 336/24 (1704–1712)

Get full text

Factors affecting the precision of warfarin treatment by Britt, R P, James, A H, Raskino, C L, Thompson, S G

Get full text

Virologic and Immunologic Response to Nucleoside Reverse-Transcriptase Inhibitor Therapy among Human Immunodeficiency Virus—Infected Infants and Children by Palumbo, Paul E., Raskino, Claire, Fiscus, Susan, Pahwa, Savita, Schutzbank, Ted, Spector, Stephen A., Baker, Carol J., Englund, Janet A.

Get full text

Comparative long-term results of coronary angioplasty in single and multivessel disease by HENDERSON, R. A., RASKINO, C., KARANI, S., SOWTON, E.

Get full text

The CCR5(delta)32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment by Barroga, Charlene F, Raskino, Claire, Fangon, Moena C, Palumbo, Paul E

Get full text

The CCR5Δ32 Allele Slows Disease Progression of Human Immunodeficiency Virus—1—Infected Children Receiving Antiretroviral Treatment by Barroga, Charlene F., Raskino, Claire, Fangon, Moena C., Palumbo, Paul E., Baker, Carol J., Englund, Janet A., Spector, Stephen A.

Get full text

The CCR5 Delta 32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment by Barroga, ChF, Raskino, C, Fangon, M C, Palumbo, P E, Baker, C J, Englund, JA, Spector, SA

Get full text

The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment by Barroga, C F, Raskino, C, Fangon, M C, Palumbo, P E, Baker, C J, Englund, J A, Spector, S A

Get full text

Predictive value of quantitative plasma HIV RNA and CD4 super(+) lymphocyte count in HIV-infected infants and children by Palumbo, P E, Raskino, C, Fiscus, S, Pahwa, S, Fowler, M G, Spector, SA, Englund, JA, Baker, C J

Get full text

Predicting HIV Disease Progression in Children Using Measures of Neuropsychological and Neurological Functioning by Pearson, Deborah A, McGrath, Nuala M, Nozyce, Molly, Nichols, Sharon L, Raskino, Claire, Brouwers, Pim, Lifschitz, Marta C, Baker, Carol J, Englund, Janet A

Get full text